Related Experiment Video
Updated: Jul 13, 2026
12:03
Purification of Biotinylated Cell Surface Proteins from Rhipicephalus microplus Epithelial Gut Cells
Published on: July 23, 2017
Targeting the tick/pathogen interface for developing new anaplasmosis vaccine strategies
K M Kocan1, J de la Fuente, E F Blouin
1Department of Veterinary Pathobiology, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, USA. Katherine.Kocan@okstate.edu
Veterinary Research Communications
|October 10, 2007
Summary
New vaccines targeting the tick-pathogen interface can combat bovine anaplasmosis. Research focused on Anaplasma marginale cell culture, adhesion proteins, and tick protective antigens to reduce disease and tick infestations.
Area of Science:
- Veterinary Parasitology
- Rickettsial Diseases
- Vaccine Development
Background:
- Bovine anaplasmosis is a global tick-borne disease caused by Anaplasma marginale.
- Current control methods vary geographically and include acaricides, antibiotics, and vaccines.
- There is a need for novel strategies to control anaplasmosis, tick infestations, and disease transmission.
Purpose of the Study:
- To develop new vaccine strategies targeting the tick-Anaplasma marginale interface.
- To reduce bovine anaplasmosis incidence, tick infestations, and the vectorial capacity of ticks.
- To explore alternative antigen sources and identify key protective antigens.
Main Methods:
- Established a cell culture system for Anaplasma marginale propagation, creating a non-bovine antigen source.
- Characterized the Anaplasma marginale adhesion protein, MSP1a.
- Identified a tick-protective antigen, subolesin, targeting tick infestations and transmission.
Main Results:
- The cell culture system provided a viable source for Anaplasma marginale vaccine antigen.
- Recombinant MSP1a in vaccine formulations reduced clinical anaplasmosis and infection levels in ticks.
- Subolesin effectively reduced tick infestations and the vectorial capacity of ticks for Anaplasma marginale.
Conclusions:
- An integrated approach targeting the tick-pathogen interface shows promise for bovine anaplasmosis control.
- Vaccine strategies utilizing Anaplasma marginale antigens and tick protective antigens can reduce disease burden.
- Further development of these strategies could lead to effective new methods for managing bovine anaplasmosis and tick-borne diseases.
Related Concept Videos
01:28Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
01:26Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.